All news (page 7)

• 

  30 March 2026

  Velocys and SuMo commission Fischer–Tropsch unit at Wednesbury for UK waste-to-SAF

  FT unit at Wednesbury is online and stable, validating integration of gasification and FT for waste-to-SAF and supporting ClearSkies demonstration toward modular, scalable SAF production.
• 

  30 March 2026

  BASF Pharma Solutions raises prices up to 20% for excipients and selected APIs

  Price change for excipients and selected APIs to support reliable supply amid rising energy and raw-material costs. Effective immediately or per contracts; company will monitor and update.
• 

  30 March 2026

  LANXESS hikes sulfur-based product prices 40%

  Immediate average 40% price increase on sulfur-based products (sulfuric acid, oleum, sodium bisulfite) due to higher sulfur, logistics and energy costs; adjustment needed to secure supplies.
• 

  30 March 2026

  Iberdrola awards €3.5bn contracts for Eastern Green Link 4 HVDC subsea interconnector

  Contracts awarded for a 640 km HVDC subsea link (2,000 MW) between Scotland and England, supplying 1.5M+ homes; construction starts 2028, commissioning 2033; part of wider UK grid investment.
• 

  30 March 2026

  TotalEnergies completes UK North Sea merger with NEO NEXT

  Merger completed; combined group renamed; one party holds a 47.5% stake. It becomes the largest independent producer on the UK Continental Shelf, with 2026 output >250,000 boe/d.
• 

  30 March 2026

  Itabus fleet adopts Enilive HVO

  Entire 100-vehicle fleet runs on HVO made from waste, cutting CO2eq by 79.5%. In 2025 it logged 20M km, used over 3M L HVO (53% avg, 75% peak in Dec).

• 

  30 March 2026

  UPM opens Adhesive Materials terminal near New Delhi

  New slitting and distribution terminal near New Delhi to boost service in Northern and Eastern India with tailored inventory and short lead times; complements Mumbai terminal; operations start Q3 2026.
• 

  30 March 2026

  UBE obtains food-contact approval for UBECycle recycled PE/PA films

  Accredited migration testing plus RecyClass‑certified recycling (following Paulowsky acquisition) confirm regulatory compliance and open use of mechanically recycled PE/PA in regulated packaging.
• 

  30 March 2026

  GSK's bepirovirsen accepted for regulatory review in China for chronic hepatitis B

  China NMPA accepted NDA for bepirovirsen after Phase III B-Well trials showed significant functional cure rates in treated CHB patients; granted Breakthrough Therapy; acceptable safety.
• 

  30 March 2026

  GSK’s Exdensur approved in China for severe eosinophilic asthma

  First ultra-long-acting IL-5 biologic for eosinophilic severe asthma; twice-yearly dosing cut annual exacerbations by ~48–58% in SWIFT trials and lowered hospital/ED visits.
• 

  30 March 2026

  Eneve acquires Nemon to enter Iberian market

  Acquisition opens Iberian market, adds 30 specialists, supports 100+ suppliers, expands platform with software for billing, forecasting, market comms and trading; integration under way
• 

  29 March 2026

  LOTTE Chemical to merge with HD Hyundai Chemical after Daesan spin-off, pivots to specialty materials

  Targets >60% specialty by 2030; building a 500k t/yr compounding plant; creating hydrogen value chain—four fuel-cell plants (80MW) and 450‑bar H2 hub; expanding high-end copper foil and TMAH output.
• 

  29 March 2026

  Merck: WINREVAIR Phase 2 CADENCE shows proof‑of‑concept in CpcPH‑HFpEF

  Met primary endpoint with significant PVR reduction at 24 weeks vs placebo. Also favorable mPAP/PAWP, NT‑proBNP and 6MWD trends, delayed clinical worsening; safety consistent with known profile.
• 

  28 March 2026

  Amgen: Repatha cuts first major cardiovascular events 31% in high‑risk patients without significant atherosclerosis

  VESALIUS‑CV subgroup (3,655 high‑risk diabetics without known atherosclerosis) showed a 31% reduction in first major CV events vs placebo; median LDL‑C 44 mg/dL over ~4.8 years.
• 

  28 March 2026

  Takeda’s Zasocitinib: Once‑daily pill achieves rapid, durable clearance in plaque psoriasis

  Phase 3: ~70% reached sPGA 0/1 at week 16; PASI90 up to 61%, PASI100 up to 33%. Responses rose through week 24 and >90% of responders maintained effect to week 60. Safety consistent with prior studies
• 

  28 March 2026

  Johnson & Johnson STEMI-DTU RCT: LV unloading with delayed reperfusion does not increase infarct size

  Neutral trial. 30‑min Impella improved pre‑PCI TIMI flow. Age 61+ trended smaller infarcts. More bleeding/vascular events but no higher 12‑month mortality. Elevated lactate predicted larger infarcts.
• 

  28 March 2026

  Johnson & Johnson: ICOTYDE (icotrokinra) 52‑week data show sustained skin clearance and favorable safety

  ICONIC Phase 3: PASI100 rose to 49%/48% (ADVANCE 1/2) by Week52; placebo switchers matched. Adolescents: 57% PASI100, 86% PASI90 at 52w. No new safety signals; fewer AEs vs deucravacitinib.
• 

  28 March 2026

  Lilly: Taltz + Zepbound superior to Taltz alone in psoriatic arthritis with obesity

  Phase 3b TOGETHER‑PsA: combination therapy improved ACR50, MDA, fatigue, function, QoL and cardiometabolic markers; 36‑week primary endpoint met (ACR50+≥10% weight loss 31.7% vs 0.8%).
• 

  27 March 2026

  EMA recommends Amgen’s Imdylltra for relapsed extensive‑stage SCLC

  EMA backs EU approval for a bispecific T‑cell engager for relapsed extensive‑stage SCLC post‑platinum; phase 3: OS 13.6 vs 8.3 months. Main risks: CRS, ICANS
• 

  27 March 2026

  Eastman raises ester prices effective April 1, 2026

  isobutyl acetate +$0.15/lb (NA, LatAm), +$0.28/lb (APAC); n-butyl (excl Eastapure) +$0.15/lb (NA, LatAm); n-propyl +$0.15/lb (NA, LatAm). Cited higher raw-material and energy costs.
• 

  27 March 2026

  TotalEnergies and EDF agree 12‑year nuclear supply for French refining and chemicals sites

  12‑year nuclear allocation (from 1 Jan 2028) will supply ~60% (~400 MW) of refining & chemical sites in France, sharing variability costs while the utility operates the plants.
• 

  27 March 2026

  Sasol — Middle East developments and business impact

  Middle East conflict disrupted gas supply - ORYX GTL shut; ~60 staff safe. Fuel and chemicals impacted; Secunda/Natref secure inventories and alternative crude; contingencies active.
• 

  27 March 2026

  aicep Global Parques strengthens park competitiveness with digital connectivity

  High-quality digital infrastructure - submarine-cable access, upgraded networks and metro proximity - boosts parks' competitiveness, attracting data centres, tech clusters and global value chains.
• 

  27 March 2026

  Lilly's EBGLYSS: durable 4‑year control in moderate‑to‑severe atopic dermatitis

  Up to four years of monthly maintenance produced durable skin clearance (EASI‑75 94%, EASI‑90 75%, IGA 0/1 68%), itch relief (Pruritus NRS≤4: 78%), 80% without topical steroids; safety consistent.
• 

  27 March 2026

  Rompetrol Rafinare completes Petromidia and Vega turnarounds

  Mechanical works finished; refineries return to staged full capacity after 700+ maintenance jobs, 6 catalyst swaps, ~900 equipment checks and ~1,200 pipeline tests; authorizations recertified.
• 

  27 March 2026

  LKAB releases 2025 Annual and Sustainability Report

  Report reviews 2025 performance: geopolitical market weakness hit results; measures to stabilise production and deliveries; social and environmental work in Gällivare & Kiruna.
• 

  27 March 2026

  Iberdrola/ScottishPower advances 960 MW East Anglia TWO offshore wind project

  €4.5bn project progressing; offshore substation foundations in production; visited by UK Energy Secretary. Will power nearly 1 million homes and support skilled jobs.
• 

  27 March 2026

  Fondazione MAIRE presents Climate Goals study in Berlin

  Fourth edition of Climate Goals study shows Germany as highly aware, pragmatic on energy transition; emphasizes technical focus, workforce upskilling, and shift of momentum toward emerging economies.
• 

  27 March 2026

  LKAB cuts Kiruna production

  Changing rock conditions force temporary shutdown of pellet plant KK3 Apr–Nov, cutting ~2 Mt deliveries in 2026. No layoffs; plant gets maintenance; other mine areas assessed; restart aimed 2027.
• 

  27 March 2026

  RWE approved for Nordseecluster B offshore wind farm

  Planning approval granted for Nordseecluster B, adding 900 MW to reach 1.6 GW (660 MW A under construction). Full output ~6.5 TWh/yr; B due early 2029; 110 MW PPA with Amazon.